Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial looked at nivolumab as the first treatment for non small cell lung cancer that has spread to another part of the body.
It was open for people to join between 2014 and 2015, and the research team reported the results in 2017.
Recruitment start: 1 March 2014
Recruitment end: 30 April 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Clive Mulatero
Bristol-Myers Squibb
Last reviewed: 27 March 2020
CRUK internal database number: 11749